4//SEC Filing
Duncan Barbara Gayle 4
Accession 0001415889-24-029472
CIK 0001636651other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 4:15 PM ET
Size
11.2 KB
Accession
0001415889-24-029472
Insider Transaction Report
Form 4
Duncan Barbara Gayle
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-12-12+90,000→ 90,000 totalExercise: $1.06Exp: 2034-12-11→ Common Stock (90,000 underlying)
Footnotes (1)
- [F1]The shares will vest in 36 equal monthly installments, subject to the Reporting Person's continued services through such date.
Documents
Issuer
Ovid Therapeutics Inc.
CIK 0001636651
Entity typeother
Related Parties
1- filerCIK 0001353128
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 4:15 PM ET
- Size
- 11.2 KB